Szymon Szymura
Overview
Explore the profile of Szymon Szymura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dong Z, Budde L, Oh E, Szymura S, Anderson A, Del Real M, et al.
Blood Adv
. 2024 Jun;
8(15):4066-4076.
PMID: 38885481
Chimeric antigen receptor (CAR) T-cell therapy has emerged as a promising immunotherapeutic strategy for eradicating human cancers. Their therapeutic success and durability of clinical responses hinges, in large part, on...
2.
Kwak L, Szymura S, Wang L, Zhang T, Cha S, Dong Z, et al.
Res Sq
. 2023 Oct;
PMID: 37790486
Lymphoplasmacytic lymphoma (LPL) is an incurable low-grade B-cell lymphoma of the bone marrow. Despite a cumulative risk of progression, there is no approved therapy for patients in the asymptomatic phase....
3.
Wang Z, Zhang T, Anderson A, Lee V, Szymura S, Dong Z, et al.
Biomedicines
. 2023 Mar;
11(3).
PMID: 36979775
Peripheral mononuclear blood cells (PBMCs) are the most widely used study materials for immunomonitoring and antigen-specific T-cell identification. However, limited patient PBMCs and low-frequency antigen-specific T cells remain as significant...
4.
Dong Z, Song J, Thieme E, Anderson A, Oh E, Cheng W, et al.
Blood Adv
. 2022 Dec;
7(6):918-932.
PMID: 36469551
B-cell activating factor receptor (BAFF-R) is a mature B-cell survival receptor, which is highly expressed in a wide variety of B-cell malignancies but with minimal expression in immature B cells....
5.
Qazilbash M, Saini N, Cha S, Wang Z, Stadtmauer E, Baladandayuthapani V, et al.
Blood
. 2021 Sep;
139(9):1289-1301.
PMID: 34521108
We hypothesized that combining adoptively transferred autologous T cells with a cancer vaccine strategy would enhance therapeutic efficacy by adding antimyeloma idiotype (Id)-keyhole limpet hemocyanin (KLH) vaccine to vaccine-specific costimulated...